See every side of every news story

Published 6 days ago • loading... • Updated 6 days ago

Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes

Summary by eurekalert.org

A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug significantly reduces cardiovascular events in people with type 2 diabetes, pre-existing cardiovascular disease, and/or chronic kidney disease.

1 Articles

1 Articles

All

Left

Center

1

Right

Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes

A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug significantly reduces cardiovascular events in people with type 2 diabetes, pre-existing cardiovascular disease, and/or chronic kidney disease.

6 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated6 days agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

eurekalert.org broke the news in 6 days ago on Sunday, March 30, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content. Stay informed with comprehensive global news coverage all in one place. Subscribe now to compare different perspectives, identify biases, and stay ahead of algorithms